Victor Kareh, MD | |
21212 Northwest Fwy, Suite 255, Cypress, TX 77429-5884 | |
(281) 970-8225 | |
(281) 970-8959 |
Full Name | Victor Kareh |
---|---|
Gender | Male |
Speciality | Neurological Surgery |
Location | 21212 Northwest Fwy, Cypress, Texas |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1194788174 | NPI | - | NPPES |
110480404 | Medicaid | TX |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207T00000X | Neurological Surgery | H9023 (Texas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Victor Kareh, MD 21212 Northwest Fwy, Suite 255, Cypress, TX 77429-5884 Ph: (281) 970-8225 | Victor Kareh, MD 21212 Northwest Fwy, Suite 255, Cypress, TX 77429-5884 Ph: (281) 970-8225 |
News Archive
Practice Fusion, the fastest growing Electronic Health Record (EHR) community in the country, announced today that it is ONC-ATCB 2011/2012 compliant and is certified as an EHR Module in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services (HHS).
The omega-3 polyunsaturated fatty acids (PUFAs) found in seafood and marine oils called EPA and DHA may offer a simple, affordable way to reduce the effects of traumatic brain and spinal cord injuries by decreasing inflammation and nerve cell damage.
Sequencing the genomes of tumor cells has revealed thousands of genetic mutations linked with cancer. However, sifting through this deluge of information to figure out which of these mutations actually drive cancer growth has proven to be a tedious, time-consuming process.
Vermillion, Inc., a leading molecular diagnostics company, today announced positive results from a new prospective, multi-center clinical study of its ovarian cancer diagnostic OVA1.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that it has initiated patient enrollment in an open-label, multi-center Phase 1b clinical trial evaluating tivozanib in combination with oral capecitabine (Xeloda®) in patients with certain advanced solid tumors.
› Verified 5 days ago
Dr. Sushrut Sunil Dharmadhikari, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 21212 Northwest Fwy Ste 645a, Cypress, TX 77429 Phone: 281-894-5310 Fax: 281-894-5313 |